Clinical Trial Update: WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing) [Phase 4]

View source ↗

Summary

Phase 4 WOEST trial update reports completion, studying the combination of antiplatelet and anticoagulant therapy in patients on oral anticoagulation undergoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease

Drugs mentioned

• Clopidogrel (Plavix) (clopidogrel)
• Warfarin (Coumadin) (warfarin)

Snippet

Sponsor: R&D Cardiologie | Conditions: Anticoagulants, Platelet Aggregation Inhibitors | Phase 4 | Status: COMPLETED